Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 34 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 7868169

    Crystalline rosuvastatin intermediate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted
  2. US 7867171

    Management of gastro-intestinal disorders

    EXALENZ BIOSCIENCE LTD. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted
  3. US 7855176

    Reduced volume formulation of glatiramer acetate and methods of administration

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  4. US 7855233

    Citrate salt of Rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  5. US 7846903

    Type II cubic liquid crystal composition

    KURARAY CO., LTD. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  6. US 7842667

    Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same

    REGENTIS BIOMATERIALS LTD. · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted
  7. US 7842717

    DNT-maleate and methods of preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted
  8. US 7825102

    Treatment of dry eye conditions

    CAN-FITE BIOPHARMA LTD. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  9. US 7815942

    Rasagiline formulations of improved content uniformity

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  10. US 7812168

    Purification of montelukast

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  11. US 7795300

    External preparation for skin

    KURARAY CO., LTD. · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted
  12. US 7777034

    Crystalline ammonium salts of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted
  13. US 7763255

    Therapeutic uses of Dunaliella powder

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  14. US 7759500

    2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  15. US 7750051

    Crystalline solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted
  16. US 7749536

    Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted
  17. US 7741482

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted
  18. US 7727602

    Recording sheet with ink receptive layer and coating liquid for forming ink receptive layer

    JGC Catalysts and Chemicals Ltd. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  19. US 7695737

    Spherical composite particles and cosmetics with the particles blended therein

    JGC Catalysts and Chemicals Ltd. · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  20. US 7692010

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  21. US 7692008

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  22. US 7692009

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  23. US 7687622

    Process for preparing quetiapine fumarate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted
  24. US 7687660

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 30, 2010 · Expires Mar 25, 2030

    granted